Immune microenvironment profiling of breast cancer brain metastases using multiplex immunofluorescence. This is an ASCO Meeting Abstract from the 2020 ASCO Annual Meeting I. This abstract does not ...
Although clinical improvement is almost universal with therapy in patients with POEMS (an acronym for polyneuropathy, organomegaly, endocrinopathies, monoclonal protein and a variety of skin changes) ...
Patients should be selected for treatment with Enhertu in combination with pertuzumab based on confirmed HER2-positive status or HER2 gene amplification (IHC 3+ or ISH+).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback